Liquiritin Protects Against Cardiac Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway

PURPOSE: Despite significant advances in interventional treatment, myocardial infarction (MI) and subsequent cardiac fibrosis remain major causes of high mortality worldwide. Liquiritin (LQ) is a flavonoid extract from licorice that possesses a variety of pharmacological properties. However, to our...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Xue, Yang, Yakun, Zhang, Muqing, Li, Li, Xue, Yucong, Jia, Qingzhong, Wang, Xiangting, Guan, Shengjiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724582/
https://www.ncbi.nlm.nih.gov/pubmed/36483459
http://dx.doi.org/10.2147/DDDT.S386805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724582/
https://www.ncbi.nlm.nih.gov/pubmed/36483459
http://dx.doi.org/10.2147/DDDT.S386805

Ejemplares similares